Clinical Trial Update: A Phase III Study of TMC435 in Genotype 1, Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy [Phase 3]

View source ↗

Summary

Phase III trial results for TMC435 in genotype 1 chronic hepatitis C patients who did not respond to prior IFN-based therapy have been completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TMC435

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2014-01-24